96
Qomel Company Limited
9600.SR · SAU
43.00 SAR +0.00% (+0.00 SAR)
1M -10.42%
Market Cap 301.0M SAR
P/E Ratio 20.12x
Div. Yield -
ROE 13.79%
Piotroski F-Score Moderate
4/9Valuation
56 /100
Fair P/E 20.12x
P/B 2.51x
EV/EBITDA 15.92x
Growth
60 /100
Stable EPS growth 16.15%
Book val. growth 54.29%
Rev. growth 19.38%
Profitability
44 /100
Moderate Gross margin 30.03%
FCF margin 19.22%
Net margin 11.31%
Quality
61 /100
Average ROE 13.79%
Asset turnover 0.61x
ROA 6.84%
Debt
95 /100
Low Debt/Equity 0.32x
Net debt/EBITDA 0.89x
Current ratio 2.31x
Stability
70 /100
Stable Beta 0.53x
Profitable years 4
Rev. volatility 14.75%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 9600.SR
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hisham Abdullah Mohammed Al-Euqala
Employees
1,043
Headquarters
Riyadh